| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $18K | -93.7% |
| Cost of Revenue | $57K | +0.0% |
| Gross Profit | $18K | -92.1% |
| R&D Expense | $5.1M | -12.5% |
| SG&A Expense | $23.1M | +7.9% |
| Operating Income | -$28.5M | -4.6% |
| Pre-tax Income | -$28.7M | -5.2% |
| Net Income | -$29.0M | -7.4% |
| EPS (Basic) | -$3.95 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $200K | -50.0% |
| Accounts Receivable | $24K | +166.7% |
| Inventory | $336K | +0.0% |
| Current Assets | $528K | -53.2% |
| Total Assets | $1.8M | -56.3% |
| Current Liabilities | $4.6M | +40.5% |
| Total Liabilities | $4.7M | +26.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.3M | +20.2% |
| Capital Expenditures | $186K | +10.7% |
| Investing Cash Flow | -$186K | -10.7% |
| Financing Cash Flow | $17.3M | +64.0% |
| Free Cash Flow | -$17.5M | +20.0% |
| +37.6% |
| EPS (Diluted) | -$3.95 | +37.6% |
| Stockholders' Equity |
| -$3.0M |
| -1064.2% |